The Everyday Protein That Reduces Blood Pressure

…and other items from this week’s health news:

Soy joy

This one’s quite impressive! A pooled analysis of 12 observational studies found that higher intake of legumes and soy foods was associated with a significantly lower risk of developing high blood pressure, with high legume intake linked to a 16% lower risk of hypertension and high soy intake linked to a 19% lower risk of hypertension.

If you want to really optimize things, the greatest benefit was seen at around 170 g/day of legumes, associated with up to a 30% lower hypertension risk, and 60–80 g/day of soy foods, associated with an additional 28–29% lower risk, with soy benefits appearing to level off above that range.

What counts as legumes and soy: legumes included peas, lentils, chickpeas, and beans, while soy foods included tofu, soy milk, edamame, tempeh, and miso.

How it works: legumes and soy are rich in potassium, magnesium, and fiber, which support blood pressure regulation, while soluble fiber fermentation may produce short-chain fatty acids that improve blood vessel health, and more specifically to soy, soy isoflavones provide additional blood pressure-lowering effects.

Of course, if you have a soy allergy, please do stick to the other legumes instead!

Read in full: This everyday plant protein may be quietly reshaping blood pressure risk in ways doctors cannot ignore

Related: What Most People Don’t Know About Blood Pressure

Mighty mitochondria

Good news: reducing insulin-like growth factor 1 (IGF-1) signaling is an anti-aging pathway, strongly linked to longer lifespan and lower risk of age-related diseases in general, meaning that you not only live longer, but also live more healthily during those extra years.

Bad news: reducing IGF-1 signaling doesn’t reliably work if mitochondrial DNA integrity is damaged, because when mitochondrial DNA is compromised, your cells’ usual stress-resistance and repair systems are weakened, which can override or blunt the life-extending benefits typically associated with lower IGF-1 signaling.

Good news: we can do things to improve our mitochondrial health!

For more on that, see these links:

Read in full: Study links mitochondrial health to effectiveness of anti-aging pathways

Related: 7 Ways To Boost Mitochondrial Health To Fight Disease

Covering all COVID bases

Researchers (Dr. Rasha El-Morsi et al.) have identified leaf compounds (known as galloylquinic acids, to their friends), that have had good lab results against the COVID virus, by targeting multiple stages of COVID infection, rather than relying on a single antiviral mechanism.

In particular, it was observed to:

• block viral entry by interfering with the spike protein’s receptor-binding processes
• disrupt viral replication by affecting RNA polymerase
• inhibit PLpro, a viral enzyme linked to immune evasion
• lower viral protein production
• reduce harmful inflammation and immune overreaction

Why this matters: this multi-target approach can lower the chance of antiviral resistance compared with drugs that focus on only one viral protein, since the virus is likely to have a harder time mutating around several simultaneous mechanisms.

Read in full: Scientists find natural compounds that hit COVID-19 from every angle

Related: Why Women Are 3x More Likely To Get Severe Long COVID

Take care!